share_log

DELFI Diagnostics to Present at American Association for Cancer Research Annual Meeting

DELFI Diagnostics to Present at American Association for Cancer Research Annual Meeting

DELFI Diagnostics将在美国癌症研究协会年会上发表演讲
PR Newswire ·  04/01 09:00
DELFI Diagnostics, Inc. (PRNewsfoto/DELFI Diagnostics)
德尔菲诊断有限公司(PRNewsFoto/Delfi Diagnostics)
FirstLook Lung is a new blood test that offers a convenient, accessible, and personalized approach to enhance lung cancer screening. FirstLook helps determine the likelihood of detecting lung cancer through low-dose CT (LDCT), with a negative predictive value of 99.8%.
FirstLook Lung 是一项全新的血液检测,为加强肺癌筛查提供了一种方便、便捷和个性化的方法。FirstLook有助于确定通过低剂量CT(LDCT)检测出肺癌的可能性,阴性预测值为99.8%。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发